|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
|
JPS57125808A
(en)
|
1981-01-30 |
1982-08-05 |
Nippon Chemiphar Co Ltd |
Preparation of cephapyrine
|
|
JPS5927900A
(ja)
|
1982-08-09 |
1984-02-14 |
Wakunaga Seiyaku Kk |
固定化オリゴヌクレオチド
|
|
US4558120A
(en)
*
|
1983-01-07 |
1985-12-10 |
The Dow Chemical Company |
Dense star polymer
|
|
FR2540122B1
(fr)
|
1983-01-27 |
1985-11-29 |
Centre Nat Rech Scient |
Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
|
|
US4605735A
(en)
|
1983-02-14 |
1986-08-12 |
Wakunaga Seiyaku Kabushiki Kaisha |
Oligonucleotide derivatives
|
|
US4948882A
(en)
|
1983-02-22 |
1990-08-14 |
Syngene, Inc. |
Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
|
|
US4824941A
(en)
|
1983-03-10 |
1989-04-25 |
Julian Gordon |
Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
|
|
US4587044A
(en)
|
1983-09-01 |
1986-05-06 |
The Johns Hopkins University |
Linkage of proteins to nucleic acids
|
|
US5118802A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
DNA-reporter conjugates linked via the 2' or 5'-primary amino group of the 5'-terminal nucleoside
|
|
US5367066A
(en)
|
1984-10-16 |
1994-11-22 |
Chiron Corporation |
Oligonucleotides with selectably cleavable and/or abasic sites
|
|
US5258506A
(en)
|
1984-10-16 |
1993-11-02 |
Chiron Corporation |
Photolabile reagents for incorporation into oligonucleotide chains
|
|
US5430136A
(en)
|
1984-10-16 |
1995-07-04 |
Chiron Corporation |
Oligonucleotides having selectably cleavable and/or abasic sites
|
|
US4828979A
(en)
|
1984-11-08 |
1989-05-09 |
Life Technologies, Inc. |
Nucleotide analogs for nucleic acid labeling and detection
|
|
FR2575751B1
(fr)
|
1985-01-08 |
1987-04-03 |
Pasteur Institut |
Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
|
|
US4762779A
(en)
|
1985-06-13 |
1988-08-09 |
Amgen Inc. |
Compositions and methods for functionalizing nucleic acids
|
|
US5317098A
(en)
|
1986-03-17 |
1994-05-31 |
Hiroaki Shizuya |
Non-radioisotope tagging of fragments
|
|
JPS638396A
(ja)
|
1986-06-30 |
1988-01-14 |
Wakunaga Pharmaceut Co Ltd |
ポリ標識化オリゴヌクレオチド誘導体
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
EP0366685B1
(en)
|
1987-06-24 |
1994-10-19 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Nucleoside derivatives
|
|
US5585481A
(en)
|
1987-09-21 |
1996-12-17 |
Gen-Probe Incorporated |
Linking reagents for nucleotide probes
|
|
US5525465A
(en)
|
1987-10-28 |
1996-06-11 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Oligonucleotide-polyamide conjugates and methods of production and applications of the same
|
|
DE3738460A1
(de)
|
1987-11-12 |
1989-05-24 |
Max Planck Gesellschaft |
Modifizierte oligonukleotide
|
|
US5082830A
(en)
|
1988-02-26 |
1992-01-21 |
Enzo Biochem, Inc. |
End labeled nucleotide probe
|
|
US5109124A
(en)
|
1988-06-01 |
1992-04-28 |
Biogen, Inc. |
Nucleic acid probe linked to a label having a terminal cysteine
|
|
US5175273A
(en)
|
1988-07-01 |
1992-12-29 |
Genentech, Inc. |
Nucleic acid intercalating agents
|
|
US5262536A
(en)
|
1988-09-15 |
1993-11-16 |
E. I. Du Pont De Nemours And Company |
Reagents for the preparation of 5'-tagged oligonucleotides
|
|
US5512439A
(en)
|
1988-11-21 |
1996-04-30 |
Dynal As |
Oligonucleotide-linked magnetic particles and uses thereof
|
|
US5457183A
(en)
|
1989-03-06 |
1995-10-10 |
Board Of Regents, The University Of Texas System |
Hydroxylated texaphyrins
|
|
US5599923A
(en)
|
1989-03-06 |
1997-02-04 |
Board Of Regents, University Of Tx |
Texaphyrin metal complexes having improved functionalization
|
|
US5391723A
(en)
|
1989-05-31 |
1995-02-21 |
Neorx Corporation |
Oligonucleotide conjugates
|
|
US4958013A
(en)
|
1989-06-06 |
1990-09-18 |
Northwestern University |
Cholesteryl modified oligonucleotides
|
|
US5451463A
(en)
|
1989-08-28 |
1995-09-19 |
Clontech Laboratories, Inc. |
Non-nucleoside 1,3-diol reagents for labeling synthetic oligonucleotides
|
|
US5134066A
(en)
|
1989-08-29 |
1992-07-28 |
Monsanto Company |
Improved probes using nucleosides containing 3-dezauracil analogs
|
|
US5254469A
(en)
|
1989-09-12 |
1993-10-19 |
Eastman Kodak Company |
Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction procedures
|
|
US5292873A
(en)
|
1989-11-29 |
1994-03-08 |
The Research Foundation Of State University Of New York |
Nucleic acids labeled with naphthoquinone probe
|
|
US5130302A
(en)
|
1989-12-20 |
1992-07-14 |
Boron Bilogicals, Inc. |
Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same
|
|
US5486603A
(en)
|
1990-01-08 |
1996-01-23 |
Gilead Sciences, Inc. |
Oligonucleotide having enhanced binding affinity
|
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
|
US5459255A
(en)
|
1990-01-11 |
1995-10-17 |
Isis Pharmaceuticals, Inc. |
N-2 substituted purines
|
|
US5681941A
(en)
|
1990-01-11 |
1997-10-28 |
Isis Pharmaceuticals, Inc. |
Substituted purines and oligonucleotide cross-linking
|
|
US5587470A
(en)
|
1990-01-11 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
3-deazapurines
|
|
WO1991013080A1
(en)
|
1990-02-20 |
1991-09-05 |
Gilead Sciences, Inc. |
Pseudonucleosides and pseudonucleotides and their polymers
|
|
US5214136A
(en)
|
1990-02-20 |
1993-05-25 |
Gilead Sciences, Inc. |
Anthraquinone-derivatives oligonucleotides
|
|
DE69032425T2
(de)
|
1990-05-11 |
1998-11-26 |
Microprobe Corp., Bothell, Wash. |
Teststreifen zum Eintauchen für Nukleinsäure-Hybridisierungsassays und Verfahren zur kovalenten Immobilisierung von Oligonucleotiden
|
|
US5218105A
(en)
|
1990-07-27 |
1993-06-08 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
|
EP0544824B1
(en)
|
1990-07-27 |
1997-06-11 |
Isis Pharmaceuticals, Inc. |
Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression
|
|
US5688941A
(en)
|
1990-07-27 |
1997-11-18 |
Isis Pharmaceuticals, Inc. |
Methods of making conjugated 4' desmethyl nucleoside analog compounds
|
|
US5608046A
(en)
|
1990-07-27 |
1997-03-04 |
Isis Pharmaceuticals, Inc. |
Conjugated 4'-desmethyl nucleoside analog compounds
|
|
US5138045A
(en)
|
1990-07-27 |
1992-08-11 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
|
US5245022A
(en)
|
1990-08-03 |
1993-09-14 |
Sterling Drug, Inc. |
Exonuclease resistant terminally substituted oligonucleotides
|
|
US5512667A
(en)
|
1990-08-28 |
1996-04-30 |
Reed; Michael W. |
Trifunctional intermediates for preparing 3'-tailed oligonucleotides
|
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
|
CA2095212A1
(en)
|
1990-11-08 |
1992-05-09 |
Hybridon, Inc. |
Incorporation of multiple reporter groups on synthetic oligonucleotides
|
|
US5371241A
(en)
|
1991-07-19 |
1994-12-06 |
Pharmacia P-L Biochemicals Inc. |
Fluorescein labelled phosphoramidites
|
|
US5594121A
(en)
|
1991-11-07 |
1997-01-14 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
|
AU3222793A
(en)
|
1991-11-26 |
1993-06-28 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
|
TW393513B
(en)
|
1991-11-26 |
2000-06-11 |
Isis Pharmaceuticals Inc |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
|
US5484908A
(en)
|
1991-11-26 |
1996-01-16 |
Gilead Sciences, Inc. |
Oligonucleotides containing 5-propynyl pyrimidines
|
|
US5565552A
(en)
|
1992-01-21 |
1996-10-15 |
Pharmacyclics, Inc. |
Method of expanded porphyrin-oligonucleotide conjugate synthesis
|
|
US5595726A
(en)
|
1992-01-21 |
1997-01-21 |
Pharmacyclics, Inc. |
Chromophore probe for detection of nucleic acid
|
|
US5272250A
(en)
|
1992-07-10 |
1993-12-21 |
Spielvogel Bernard F |
Boronated phosphoramidate compounds
|
|
EP0673559A1
(en)
|
1992-12-14 |
1995-09-27 |
Honeywell Inc. |
Motor system with individually controlled redundant windings
|
|
US5574142A
(en)
|
1992-12-15 |
1996-11-12 |
Microprobe Corporation |
Peptide linkers for improved oligonucleotide delivery
|
|
US5502177A
(en)
|
1993-09-17 |
1996-03-26 |
Gilead Sciences, Inc. |
Pyrimidine derivatives for labeled binding partners
|
|
US5457187A
(en)
|
1993-12-08 |
1995-10-10 |
Board Of Regents University Of Nebraska |
Oligonucleotides containing 5-fluorouracil
|
|
US5596091A
(en)
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
|
US5525711A
(en)
|
1994-05-18 |
1996-06-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Pteridine nucleotide analogs as fluorescent DNA probes
|
|
US5597696A
(en)
|
1994-07-18 |
1997-01-28 |
Becton Dickinson And Company |
Covalent cyanine dye oligonucleotide conjugates
|
|
US5580731A
(en)
|
1994-08-25 |
1996-12-03 |
Chiron Corporation |
N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
|
|
US5820873A
(en)
|
1994-09-30 |
1998-10-13 |
The University Of British Columbia |
Polyethylene glycol modified ceramide lipids and liposome uses thereof
|
|
US6156564A
(en)
|
1996-06-07 |
2000-12-05 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cellular apoptosis susceptibility protein (CSP) and antisense CSP
|
|
US6197787B1
(en)
|
1997-03-03 |
2001-03-06 |
Sanofi-Synthelabo |
Pharmaceutical formulations containing poorly soluble drug substances
|
|
US6770748B2
(en)
|
1997-03-07 |
2004-08-03 |
Takeshi Imanishi |
Bicyclonucleoside and oligonucleotide analogue
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US6126995A
(en)
|
1997-09-30 |
2000-10-03 |
The United States Of America As Represented By The Secretary Of The Navy |
Process for producing stable divalent scandium
|
|
DE19743269A1
(de)
|
1997-09-30 |
1999-04-01 |
Siemens Ag |
Herstellverfahren für eine Bi-haltige keramische Schicht
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
KR20010042069A
(ko)
|
1998-03-20 |
2001-05-25 |
베니텍 오스트레일리아 리미티드 |
유전자 발현 조절방법
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
AU3751299A
(en)
|
1998-04-20 |
1999-11-08 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
|
|
US6199844B1
(en)
|
1998-07-27 |
2001-03-13 |
Chrysler Corporation |
Striker cap for vehicle suspension system
|
|
US6098957A
(en)
|
1998-07-31 |
2000-08-08 |
Honeywell Inc. |
Electro-mechanical torque limiter for valve actuators
|
|
US6186231B1
(en)
|
1998-11-20 |
2001-02-13 |
Texaco Inc. |
Conformance improvement in hydrocarbon bearing underground strata using lignosulfonate-acrylic acid graft copolymer gels
|
|
AU776362B2
(en)
|
1999-05-04 |
2004-09-09 |
Roche Innovation Center Copenhagen A/S |
L-ribo-LNA analogues
|
|
US6525191B1
(en)
|
1999-05-11 |
2003-02-25 |
Kanda S. Ramasamy |
Conformationally constrained L-nucleosides
|
|
WO2001029058A1
(en)
|
1999-10-15 |
2001-04-26 |
University Of Massachusetts |
Rna interference pathway genes as tools for targeted genetic interference
|
|
US6989574B2
(en)
|
2000-08-24 |
2006-01-24 |
Heetronix |
High temperature circuit structures with thin film layer
|
|
US7053150B2
(en)
*
|
2000-12-18 |
2006-05-30 |
Nektar Therapeutics Al, Corporation |
Segmented polymers and their conjugates
|
|
US20040019001A1
(en)
|
2002-02-20 |
2004-01-29 |
Mcswiggen James A. |
RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA
|
|
US7314956B2
(en)
*
|
2001-08-08 |
2008-01-01 |
Vaxim, Inc. |
Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell
|
|
JP2003181751A
(ja)
|
2001-12-17 |
2003-07-02 |
Shirai Tekkosho:Kk |
板ガラスのエッジ面取機
|
|
KR20030055020A
(ko)
|
2001-12-26 |
2003-07-02 |
주식회사 포스코 |
연주기 몰드 진동장치
|
|
US6987930B2
(en)
|
2002-08-27 |
2006-01-17 |
Pentax Corporation |
Lens barrel incorporating the advancing/retracting mechanism
|
|
EP1562971B1
(en)
|
2002-11-05 |
2014-02-12 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
AU2003295387A1
(en)
|
2002-11-05 |
2004-06-03 |
Isis Parmaceuticals, Inc. |
Modified oligonucleotides for use in rna interference
|
|
KR100916379B1
(ko)
|
2003-01-10 |
2009-09-07 |
사천홍시현시기건유한공사 |
유기 전기발광 소자의 캐소드 패드 제조방법
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
DK1661905T3
(da)
|
2003-08-28 |
2012-07-23 |
Takeshi Imanishi |
Hidtil ukendte syntetiske nukleinsyrer af N-O-krydsbindingstype
|
|
AU2004274021B2
(en)
|
2003-09-18 |
2009-08-13 |
Isis Pharmaceuticals, Inc. |
4'-thionucleosides and oligomeric compounds
|
|
ES2547220T3
(es)
*
|
2004-04-20 |
2015-10-02 |
Dendritic Nanotechnologies, Inc. |
Polímeros dendríticos con amplificación y funcionalidad interior mejoradas
|
|
US7985424B2
(en)
*
|
2004-04-20 |
2011-07-26 |
Dendritic Nanotechnologies Inc. |
Dendritic polymers with enhanced amplification and interior functionality
|
|
CN102940891B
(zh)
*
|
2004-05-05 |
2016-02-24 |
赛伦斯治疗有限公司 |
脂质、脂质复合物及其应用
|
|
GB0422877D0
(en)
*
|
2004-10-14 |
2004-11-17 |
Univ Glasgow |
Bioactive polymers
|
|
EP1912679A4
(en)
|
2005-06-15 |
2009-07-29 |
Massachusetts Inst Technology |
AMINOUS LIPIDS AND ITS USES
|
|
TWI384032B
(zh)
*
|
2005-12-21 |
2013-02-01 |
Dendritic Nanotechnologies Inc |
具有增強的放大率及內部官能度的樹枝狀聚合物
|
|
WO2007073489A2
(en)
*
|
2005-12-22 |
2007-06-28 |
Trustees Of Boston University |
Molecules for gene delivery and gene therapy, and methods of use thereof
|
|
CA2640171C
(en)
|
2006-01-27 |
2014-10-28 |
Isis Pharmaceuticals, Inc. |
6-modified bicyclic nucleic acid analogs
|
|
JP5441688B2
(ja)
|
2006-05-11 |
2014-03-12 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
５’修飾二環式核酸類似体
|
|
CA2658768C
(en)
|
2006-07-21 |
2016-05-17 |
Massachusetts Institute Of Technology |
End-modified poly(beta-amino esters) and uses thereof
|
|
US20080068922A1
(en)
|
2006-09-12 |
2008-03-20 |
Voss Klaus-W |
Device for blending a binder component and a hardener component for producing a ready-made filler
|
|
KR20080039618A
(ko)
|
2006-11-01 |
2008-05-07 |
엘지전자 주식회사 |
이동통신 단말기의 데이터 서비스 방법
|
|
WO2008101157A1
(en)
|
2007-02-15 |
2008-08-21 |
Isis Pharmaceuticals, Inc. |
5'-substituted-2'-f modified nucleosides and oligomeric compounds prepared therefrom
|
|
EP2170917B1
(en)
|
2007-05-30 |
2012-06-27 |
Isis Pharmaceuticals, Inc. |
N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
|
|
US20080294089A1
(en)
*
|
2007-06-06 |
2008-11-27 |
Biovaluation & Analysis, Inc. |
Dendritic Polymers for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
|
|
ES2386492T3
(es)
|
2007-06-08 |
2012-08-21 |
Isis Pharmaceuticals, Inc. |
Análogos de ácidos nucleicos bicíclicos carbocíclicos
|
|
CN101796062B
(zh)
|
2007-07-05 |
2014-07-30 |
Isis制药公司 |
6-双取代双环核酸类似物
|
|
US8637478B2
(en)
*
|
2007-11-13 |
2014-01-28 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating protein expression
|
|
WO2010053572A2
(en)
|
2008-11-07 |
2010-05-14 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
US20110305769A1
(en)
*
|
2008-11-17 |
2011-12-15 |
Enzon Pharmaceuticals, Inc. |
Branched cationic lipids for nucleic acids delivery system
|
|
US8163861B2
(en)
|
2009-01-15 |
2012-04-24 |
Living Proof, Inc. |
Beta-amino ester compounds and uses thereof
|
|
EP2437756A2
(en)
|
2009-06-02 |
2012-04-11 |
Wu, Nian |
Pure peg-lipid conjugates
|
|
CN101591428B
(zh)
*
|
2009-06-29 |
2011-05-25 |
浙江大学 |
一种聚酯树枝状大分子的制备方法
|
|
CA2800401C
(en)
*
|
2010-06-03 |
2020-09-15 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
US20130323269A1
(en)
*
|
2010-07-30 |
2013-12-05 |
Muthiah Manoharan |
Methods and compositions for delivery of active agents
|
|
JP5136634B2
(ja)
|
2010-12-17 |
2013-02-06 |
オムロン株式会社 |
端子台装置
|
|
WO2012090223A1
(en)
|
2010-12-29 |
2012-07-05 |
Indian Institute Of Science |
Poly(ether imine) dendrimers and uses thereof
|
|
AU2012267467B8
(en)
|
2011-06-08 |
2017-06-15 |
Nitto Denko Corporation |
Compounds for targeting drug delivery and enhancing siRNA activity
|
|
WO2013146922A1
(ja)
|
2012-03-27 |
2013-10-03 |
株式会社ニコン |
振動アクチュエータ、レンズ鏡筒及び電子機器
|
|
PL4289948T3
(pl)
|
2012-05-25 |
2025-06-02 |
The Regents Of The University Of California |
Sposoby i kompozycje do modyfikacji kierowanego na rna docelowego dna i do nakierowanej na rna modulacji transkrypcji
|
|
EP2885318A4
(en)
|
2012-08-14 |
2016-03-30 |
Angiochem Inc |
PEPTIDE DENDRIMER CONJUGATES AND ITS USES
|
|
JP6241193B2
(ja)
|
2012-10-23 |
2017-12-06 |
コニカミノルタ株式会社 |
透明電極、電子デバイス及び有機エレクトロルミネッセンス素子
|
|
JP6186231B2
(ja)
|
2013-10-01 |
2017-08-23 |
株式会社日立製作所 |
鉄道車両用駆動システム
|
|
CN103999853B
(zh)
*
|
2014-06-11 |
2015-07-22 |
中国农业大学 |
荧光树枝状纳米大分子在制备药物载体中的应用
|
|
JP6199844B2
(ja)
|
2014-10-31 |
2017-09-20 |
日本電信電話株式会社 |
被疑箇所推定装置及び被疑箇所推定方法
|
|
AU2015360794B2
(en)
*
|
2014-12-08 |
2021-07-08 |
The Board Of Regents Of The University Of Texas System |
Lipocationic polymers and uses thereof
|
|
US11247968B2
(en)
*
|
2015-09-14 |
2022-02-15 |
The Board Of Regents Of The University Of Texas System |
Lipocationic dendrimers and uses thereof
|
|
WO2017201091A1
(en)
*
|
2016-05-16 |
2017-11-23 |
The Board Of Regents Of The University Of Texas System |
COMPOSITIONS FOR THE DELIVERY OF tRNA AS NANOPARTICLES AND METHODS OF USE THEREWITH
|
|
JP6156564B1
(ja)
|
2016-09-28 |
2017-07-05 |
株式会社メイショーテクノ |
試料設置台
|
|
US12357580B2
(en)
*
|
2018-06-19 |
2025-07-15 |
The Board Of Regents Of The University Of Texas System |
Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
|
|
GB2596224B
(en)
*
|
2018-06-19 |
2022-09-07 |
Univ Texas |
Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
|
|
WO2020051220A1
(en)
*
|
2018-09-04 |
2020-03-12 |
The Board of the Regents of the University of Texas System |
Compositions and methods for organ specific delivery of nucleic acids
|
|
WO2022204219A1
(en)
*
|
2021-03-22 |
2022-09-29 |
Recode Therapeutics, Inc. |
Compositions and methods for targeted delivery to cells
|
|
WO2022204043A1
(en)
*
|
2021-03-22 |
2022-09-29 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for targeted delivery to cells
|
|
WO2022216619A1
(en)
*
|
2021-04-05 |
2022-10-13 |
The Board Of Regents Of The University Of Texas System |
Compositions, methods and uses for treating cystic fibrosis and related disorders
|
|
US20240261440A1
(en)
*
|
2021-04-05 |
2024-08-08 |
The Board Of Regents Of The University Of Texas System |
Compositions, methods and uses for treating cystic fibrosis and related disorders
|
|
AU2022262422A1
(en)
*
|
2021-04-22 |
2023-11-02 |
The Board Of Regents Of The University Of Texas System |
All-in-one dendrimer-based lipid nanoparticles enable precise hdr-mediated gene editing in vivo
|
|
WO2023215790A1
(en)
*
|
2022-05-03 |
2023-11-09 |
The Board Of Regents Of The University Of Texas System |
Co-delivery of inhibitory nucleic acids and genome editors for tumor therapy
|